Basis: (FMP quote price / unrounded diluted TTM EPS) / explicitly dated EPS growth percent. Source: stored company filings and market data; unavailable inputs remain N/A.
The PEG ratio is N/A as of 2026-09-19T00:15:43.163Z.
Calculation as of: 2026-09-19T00:15:43.163Z.
Quote observation: 2026-09-18T20:00:01.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 16d9fb761af4d4f75fbdea9cd0c33bad22e8ff133c571a16cba71ffd353317c6
PEG RATIO
N/A
Incyte Corporation
Market Cap
$25.40B
PEG Ratio
N/A
| NAME | MARKET CAP | PEG RATIO |
|---|---|---|
| Incyte Corporation (INCY) | $25.40B | N/A |
| West Pharmaceutical Services, Inc. (WST)vs › | $25.49B | N/A |
| Labcorp Holdings Inc. (LH)vs › | $26.30B | N/A |
| BioNTech SE (BNTX)vs › | $24.13B | N/A |
| Medline Inc. (MDLN)vs › | $26.75B | N/A |
| Quest Diagnostics Incorporated (DGX)vs › | $27.20B | N/A |
| Mettler-Toledo International Inc. (MTD)vs › | $28.14B | N/A |
| GE HealthCare Technologies Inc. (GEHC)vs › | $28.97B | N/A |
| United Therapeutics Corporation (UTHR)vs › | $21.00B | N/A |
| Zoetis Inc. (ZTS)vs › | $29.95B | N/A |
PEG Ratio
N/A
P/E Ratio
16.0
PEG Ratio = PE Ratio / Earnings Growth Rate
The PEG ratio adjusts the PE ratio for expected earnings growth. A PEG near 1 is often considered fairly valued relative to growth.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
